• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粉防己碱和维拉帕米对门静脉高压大鼠的门静脉降压作用。

Portal hypotensive effects of tetrandrine and verapamil in portal hypertensive rats.

作者信息

Liu T B, Lin H C, Huang Y T, Sun C M, Hong C Y

机构信息

Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

J Pharm Pharmacol. 1997 Jan;49(1):85-8. doi: 10.1111/j.2042-7158.1997.tb06757.x.

DOI:10.1111/j.2042-7158.1997.tb06757.x
PMID:9120776
Abstract

The portal hypotensive effects of tetrandrine and verapamil (both calcium-channel blockers) were assessed in portal hypertensive rats. Portal hypertension was induced by partial portal vein ligation in Sprague-Dawley rats. Both tetrandrine (4, 8, 16 and 24 mg kg-1) and verapamil (0.5, 1.0, 1.5 and 2.0 mg kg-1) induced dose-dependent decreases of portal venous pressure and mean arterial pressure after intravenous infusion. for example, infusion of tetrandrine (16 mg kg-1) induced a maximum reduction of portal venous pressure and mean arterial pressure approximately 1 min after the start of infusion. Portal venous pressure decreased from baseline (12.5 mmHg) to 10.0 mmHg, and mean arterial pressure from baseline (90 mmHg) to 80 mmHg. Heart rate decreased from 250 to 240 beats min-1. At 24 mg kg-1, tetrandrine reduced portal venous pressure and mean arterial pressure to 20.3 +/- 2.4% and 28.4 +/- 1.4% of baseline, respectively. Our results show that both tetrandrine and verapamil induce portal pressure reduction in portal hypertensive animals.

摘要

在门静脉高压大鼠中评估了粉防己碱和维拉帕米(两者均为钙通道阻滞剂)的门脉降压作用。门静脉高压通过在Sprague-Dawley大鼠中部分门静脉结扎诱导产生。静脉输注后,粉防己碱(4、8、16和24 mg kg-1)和维拉帕米(0.5、1.0、1.5和2.0 mg kg-1)均引起门静脉压力和平均动脉压的剂量依赖性降低。例如,输注粉防己碱(16 mg kg-1)在输注开始后约1分钟诱导门静脉压力和平均动脉压最大程度降低。门静脉压力从基线(12.5 mmHg)降至10.0 mmHg,平均动脉压从基线(90 mmHg)降至80 mmHg。心率从250次/分钟降至240次/分钟。在24 mg kg-1时,粉防己碱分别将门静脉压力和平均动脉压降至基线的20.3±2.4%和28.4±1.4%。我们的结果表明,粉防己碱和维拉帕米均可使门静脉高压动物的门静脉压力降低。

相似文献

1
Portal hypotensive effects of tetrandrine and verapamil in portal hypertensive rats.粉防己碱和维拉帕米对门静脉高压大鼠的门静脉降压作用。
J Pharm Pharmacol. 1997 Jan;49(1):85-8. doi: 10.1111/j.2042-7158.1997.tb06757.x.
2
Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.急性给予粉防己碱和特利加压素对门静脉高压大鼠的血流动力学影响。
Can J Physiol Pharmacol. 1997 Oct-Nov;75(10-11):1220-5.
3
Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats.汉防己甲素长期治疗对门静脉高压大鼠的血流动力学影响
J Gastroenterol Hepatol. 1997 Aug;12(8):585-9. doi: 10.1111/j.1440-1746.1997.tb00490.x.
4
Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
Pharmacology. 1997 May;54(5):225-31. doi: 10.1159/000139490.
5
Haemodynamic effects of chronic octreotide and tetrandrine administration in portal hypertensive rats.慢性给予奥曲肽和粉防己碱对门静脉高压大鼠的血流动力学影响。
J Gastroenterol Hepatol. 1998 Mar;13(3):266-72. doi: 10.1111/j.1440-1746.1998.01554.x.
6
Acute hemodynamic effects of tetramethylpyrazine and tetrandrine on cirrhotic rats.川芎嗪和汉防己甲素对肝硬化大鼠的急性血流动力学效应
Planta Med. 1999 Mar;65(2):130-4. doi: 10.1055/s-1999-13973.
7
Hemodynamic effects of chronic tetrandrine treatment in Sprague-Dawley rats.汉防己甲素长期治疗对Sprague-Dawley大鼠的血流动力学影响。
Chin J Physiol. 1997 Sep 30;40(3):175-8.
8
Effects of tetramethylpyrazine on portal hypertensive rats.川芎嗪对门静脉高压大鼠的影响。
J Pharm Pharmacol. 1998 Aug;50(8):881-4. doi: 10.1111/j.2042-7158.1998.tb04003.x.
9
Calcium channel blockers in cirrhotic patients with portal hypertension.肝硬化门静脉高压患者中的钙通道阻滞剂
Chin Med J (Engl). 1995 Nov;108(11):803-8.
10
Portal hypotensive effects of DL-028 and prazosin on portal hypertensive rats.DL-028和哌唑嗪对门静脉高压大鼠的门静脉降压作用。
Pharmacology. 1998 Sep;57(3):132-8. doi: 10.1159/000028234.

引用本文的文献

1
Structural bases of inhibitory mechanism of Ca1.2 channel inhibitors.钙通道抑制剂抑制机制的结构基础。
Nat Commun. 2024 Mar 30;15(1):2772. doi: 10.1038/s41467-024-47116-8.
2
Progress in studies of tetrandrine against hepatofibrosis.粉防己碱抗肝纤维化的研究进展
World J Gastroenterol. 1998 Oct;4(5):377-379. doi: 10.3748/wjg.v4.i5.377.